MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash
$2,835,916
Prepaid expenses and
other current assets
$1,716,836
Grant receivable
$198,296
Total current assets
$4,751,048
Deferred offering costs
$455,726
Property and equipment,
net of depreciation
$19,908
Total assets
$5,226,682
Total liabilities and
stockholders' equity...
$5,226,682
Total liabilities
$3,800,703
Total stockholders'
equity (deficit)
$1,425,979
Accumulated deficit
-$84,419,882
Total current
liabilities
$2,967,828
Long-term liabilities
$832,875
Additional paid-in capital
$85,845,777
Common stock - 0.0001
par value,...
$84
Accounts payable and
accrued expenses
$2,967,828
Warrant liability
$832,875
Back
Back
Balance Sheet
source: myfinsight.com
Transcode Therapeutics, Inc. (RNAZ)
Transcode Therapeutics, Inc. (RNAZ)